ASP Isotopes Inc. (ASPI)
- Previous Close
3.0100 - Open
3.1500 - Bid 3.0700 x 400
- Ask 3.1400 x 500
- Day's Range
3.0700 - 3.2900 - 52 Week Range
0.8700 - 5.6700 - Volume
436,921 - Avg. Volume
988,265 - Market Cap (intraday)
207.063M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.6200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
4.50
ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.
aspisotopes.comRecent News: ASPI
View More
Performance Overview: ASPI
Trailing total returns as of 10/4/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ASPI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ASPI
View MoreValuation Measures
Market Cap
200.73M
Enterprise Value
203.82M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
54.71
Price/Book (mrq)
18.23
Enterprise Value/Revenue
88.79
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-39.33%
Return on Equity (ttm)
-197.74%
Revenue (ttm)
2.3M
Net Income Avi to Common (ttm)
-27.05M
Diluted EPS (ttm)
-0.6200
Balance Sheet and Cash Flow
Total Cash (mrq)
28.26M
Total Debt/Equity (mrq)
218.34%
Levered Free Cash Flow (ttm)
-7.22M
Research Analysis: ASPI
View MoreCompany Insights: ASPI
ASPI does not have Company Insights